Determination of phenobarbitone population clearance values for South African children.
Non-liner Mixed Effects Modelling (NON-MEM) was used to estimate phenobarbitone population clearance values for South African children, using 52 serum levels gathered from 32 patients during their routine care. NONMEM was also used to evaluate the influence of fixed effects such as weight, age and concomitant medication. The final model describing phenobarbitone clearance was CL = [Exp(0.0288 Wt - 2.53)]M, where CL clearance (l x h(-1)), Exp = the base of the natural logarithm, Wt = patient weight (kg) and M = a scaling factor for concomitant medication with a value of 1 for patients on phenobarbitone monotherapy, 0.62 for those receiving concomitant valproate and 0.87 for those patients receiving concomitant carbamazepine or phenytoin. Mean (95% confidence interval) phenobarbitone clearance values were 7.6 ml x h(-1) x kg(-1) (6.2, 9.0 ml x h(-1) x kg(-1) for the monotherapy group, 5.0 ml x h(-1) x hg(-1) (4.0, 6.0 ml x h(-1) x kg(-1)) in the presence of concomitant valproate and 6.8 ml x h(-1) x kg(-1) (5.6, 8.0 ml x h(-1) x kg(-1)) in the presence of concomitant carbamazepine or phenytoin. These values are similar to those previously reported from both traditional and NONMEM pharmacokinetic studies.
Botha
J H
JH
Department of Clinical and Experimental Pharmacology, University of Natal, South Africa.
Gray
A L
AL
Miller
R
R
D000927:Anticonvulsants / Q000097:blood / Q000493:pharmacokinetics*; D001835:Body Weight / Q000502:physiology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007206:Individuality; D008297:Male; D010634:Phenobarbital / Q000097:blood / Q000493:pharmacokinetics*; D013019:South Africa
D000927:Anticonvulsants; D010634:Phenobarbital